Biotech is guessing how Vinay Prasad might change the FDA. His research, writing offer clues

biopharmadive.com/news/vinay-prasad-cber-fda-drug-approvals-research/747497

To hear Vinay Prasad tell it, U.S. healthcare is too ready to intervene unnecessarily, use prescription drugs without sufficient evidence of their benefit and put patients at risk of side effects or other negative outcomes.
The Food and Drug Administration has, in Prasad’s opinion,…

This story appeared on biopharmadive.com, 2025-05-09 04:08:22.901000.
The Entire Business World on a Single Page. Free to Use →